Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (73)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scheidt-Nave, C.
Right arrow Articles by Edelstein, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheidt-Nave, C.
Right arrow Articles by Edelstein, S. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 133, No. 6: 565-576
Copyright © 1991 by The Johns Hopkins University School of Hygiene and Public Health


research-article

Sex Differences in Fasting Glycemia as a Risk Factor for Ischemic Heart Disease Death

Christa Scheidt-Nave1,, Elizabeth Barrett-Connor1, Deborah L. Wingard1, Barbara A. Cohn2 and Sharon L. Edelstein1

1Department of Community and Family Medicine, University of California, San Diego, School of Medicine La Jolla, CA
2Human Population Laboratory, California Public Health Foundation Berkeley, CA

Reprint requests to Dr. Christa Scheidt-Nave, Department of Community and Family Medicine, M-007, 9500 Gilman Drive, University of California, San Diego, La Jolla, CA 92093-0607

The relation between fasting plasma glucose and mortality from ischemic heart disease was examined in a population of 3,458 nondiabetics (aged 40–79 years) in Rancho Bemardo, California, who were free of heart disease at baseline and were followed for an average of 14 years, from 1972 to 1987. A linear increase of age-adjusted ischemic heart disease mortality rates with fasting glucose was observed in men, and a threshold relation at 110 mg/100 ml plasma glucose was observed in women. On the basis of Cox proportional hazards analysis, the observed sex differential in the association between plasma glucose and ischemic heart disease mortality proved to be statistically significant and independent of the effects of age, systolic blood pressure, body mass index, plasma cholesterol, plasma triglyceride, and, in women, estrogen use. In sex-specific multivariate models, interaction terms representing a threshold effect at glucose levels ≥110 mg/100 ml were statistically significant in women (p = 0.007), but not in men, and interaction between sex and the glucose threshold term was observed in multivariate analysis of men and women combined (p = 0.07). The authors conclude that sex differences in the effect of fasting glycemia on ischemic heart disease mortality among nondiabetics exist and are unexplained. Elucidation may hold a key to the sex difference in heart disease and the relatively greater importance of diabetes and impaired glucose tolerance as risk factors for ischemic heart disease in women compared with men.

coronary disease; glucose; sex characteristics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A.-M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
Eur. Heart J., July 1, 2005; 26(13): 1255 - 1261.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K.-T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day
Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk
Ann Intern Med, September 21, 2004; 141(6): 413 - 420.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe
Women and Heart Disease: The Role of Diabetes and Hyperglycemia
Arch Intern Med, May 10, 2004; 164(9): 934 - 942.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. M. Newton, A. Z. LaCroix, S. R. Heckbert, L. Abraham, D. McCulloch, and W. Barlow
Estrogen Therapy and Risk of Cardiovascular Events Among Women With Type 2 Diabetes
Diabetes Care, October 1, 2003; 26(10): 2810 - 2816.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Arterioscler Thromb Vasc Biol, February 14, 2003; 23(2): 314 - 321.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
J Sala, R Masia, F-J Gonzalez de Molina, J M Fernandez-Real, M Gil, D Bosch, W Ricart, M Senti, and J Marrugat
Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission
J Epidemiol Community Health, September 1, 2002; 56(9): 707 - 712.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. W. Newcomer, D. W. Haupt, R. Fucetola, A. K. Melson, J. A. Schweiger, B. P. Cooper, and G. Selke
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Arch Gen Psychiatry, April 1, 2002; 59(4): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
N. L. Smith, J. I. Barzilay, D. Shaffer, P. J. Savage, S. R. Heckbert, L. H. Kuller, R. A. Kronmal, H. E. Resnick, and B. M. Psaty
Fasting and 2-Hour Postchallenge Serum Glucose Measures and Risk of Incident Cardiovascular Events in the Elderly: The Cardiovascular Health Study
Arch Intern Med, January 28, 2002; 162(2): 209 - 216.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
DECODE Study Group; on behalf of the European Diab
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
Arch Intern Med, February 12, 2001; 161(3): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
K.-T. Khaw, N. Wareham, R. Luben, S. Bingham, S. Oakes, A. Welch, and N. Day
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
BMJ, January 6, 2001; 322(7277): 15 - 15.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. C. Gerstein, P. Pais, J. Pogue, and S. Yusuf
Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study
J. Am. Coll. Cardiol., March 1, 1999; 33(3): 612 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Cagnacci, E. Mallus, F. Tuveri, R. Cirillo, A. M. Setteneri, and G. B. Melis
Effect of Tibolone on Glucose and Lipid Metabolism in Postmenopausal Women
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 251 - 253.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. H. Alderman, S. Madhavan, H. Cohen, J. E. Sealey, and J. H. Laragh
Low Urinary Sodium Is Associated With Greater Risk of Myocardial Infarction Among Treated Hypertensive Men
Hypertension, June 1, 1995; 25(6): 1144 - 1152.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.